Takeda - BlackDoctor

The Global Alzheimer’s Platform Foundation (GAP) is a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those living with Alzheimer’s and Parkinson’s by reducing the time and cost of Alzheimer’s disease (AD) and Parkinson’s disease (PD) clinical trials.

A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Stratified by Prior Biologic Use

Condition: Psoriatic Arthritis

Drugs: Placebo, Zasocitinib

Trial ID: TAK-279-PsA-3002

Age: 18 years and older

Phase: 3

See If You Qualify

A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying

Condition: Psoriatic Arthritis

Drugs: Placebo, Zasocitinib, Active Comparator

Trial ID: TAK-279-PsA-3001

Age: 18 years and older

Phase: 3

See If You Qualify

Where Culture Meets Care

BlackDoctor is the world’s largest and most comprehensive online health resource specifically for the Black community. BlackDoctor understands that the uniqueness of Black culture - our heritage and our traditions - plays a role in our health. BlackDoctor gives you access to innovative new approaches to the health information you need in everyday language so you can break through the disparities, gain control and live your life to its fullest.

The Most Popular Anxiety Drug, Xanax, is Being Recalled

“I Was in Labor for Two Days—and Didn’t Know It”: Why Speaking Up Can Save Black Mothers

How a Lack of Sleep Can Widen Your Waistline

Where Culture Meets Care

Where Culture Meets Care

Download PDF